P
Pap smear |
Parainfluenza type 1 (PIV-1) |
Parainfluenza type 2 (PIV-2) |
Parainfluenza type 3 (PIV-3) |
Parainfluenza type 4 (PIV-4) |
ParvoVirous B19 |
PDGFRB(5q33) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
Plasma Cell Leukemia panel at diagnosis ( 12-16 CD markers) |
Plasma Cell Leukemia panel for MRD ( 8-12 CD markers) |
Plasma Cell Myeloma panel at diagnosis ( 12-16 CD markers) |
Plasma Cell Myeloma panel for MRD ( 8-12 CD markers) |
Plasminogen Activator Inhibitor-1 (PAI-1) gene 675 4G/5G |
Plasminogen Activator Inhibitor-1 (PAI-1) gene 844 A/G |
Plasmodium falciparum |
Plasmodium vivax |
Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 2 |
Plavix or Clopidogrel resitance or Cyp2c19 Genotyping for Plavix or Clopidogrel – Genotype 3 |
PLZF-RARA |
PML/RARA t(15;17)(15q24,17q21) for AML-M3 |
Pneumocystis jiroveci (carinii) |
Pneumocystis jiroveci (carinii) |
PNH Panel Granulocyte/Monocyte & Erytrocyte (10-14 CD markers) |
Prothrombin (Factor II)/ G20210A Mutation |